Suchergebnisse
H&R Block Inc.
WKN: 859376 / Symbol: HRB / Name: H&R Block / Aktie / Persönl. & Haushaltsprodukte & -dienstleistungen / Mid Cap /
Haier Electronics Group Corp Ltd
WKN: A0MJ98 / Symbol: HRELF / Name: Haier Electronics / Aktie / Haushaltsgüter / Large Cap /
Heron Therapeutics Inc.
WKN: A1XB6K / Symbol: HRTX / Name: Heron Inc / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
HKR International Ltd
WKN: 877147 / Symbol: HRKIF / Name: HKR International / Aktie / Operativer Immobilienhandel / Small Cap /
Healthcare Realty Trust
WKN: 886627 / Symbol: HR / Name: Healthcare Real / Aktie / REITs / Mid Cap /
Hormel Foods Corp.
WKN: 850875 / Symbol: HRL / Name: Hormel Foods / Aktie / Essen & Tabak / Large Cap /
Harrow Health Inc.
WKN: A2PBJD / Symbol: HROW / Name: Harrow Health / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
HRMY vs. AMGN: Which Stock Is the Better Value Option?
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Harmony Biosciences Holdings, Inc. (HRMY) and Amgen (AMGN). But which of these two companies is the best
Wall Street Analysts See a 27.35% Upside in Harmony Biosciences (HRMY): Can the Stock Really Move This High?
Harmony Biosciences Holdings, Inc. (HRMY) closed the last trading session at $34.81, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
HRMY Posts Preliminary Q2 Revenues, Announces CFO Transition
Harmony Biosciences HRMY announced preliminary second-quarter 2026 results.
The company registered a record $261 million in net product revenues from its lead drug, Wakix (pitolisant).
Wakix
Herc Holdings (HRI) Expected to Beat Earnings Estimates: Should You Buy?
The market expects Herc Holdings (HRI) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus
Herc Holdings (HRI) Q2 Earnings and Revenues Surpass Estimates
Herc Holdings (HRI) came out with quarterly earnings of $1.43 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $1.87 per share a year ago. These
Harmony Biosciences Holdings, Inc. (HRMY) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Harmony Biosciences Holdings, Inc. (HRMY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This
HRMY or ACAD: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Harmony Biosciences Holdings, Inc. (HRMY) or Acadia Pharmaceuticals (ACAD). But which of
Spectrum Brands Holdings, Inc
WKN: A2NB43 / Symbol: SPB / Name: Spectrum Brands Holdings / Aktie / Persönl. & Haushaltsprodukte & -dienstleistungen / Mid Cap /
L3Harris Technologies Inc.
WKN: A2PM3H / Symbol: LHX / Name: L3Harris Technologies / Aktie / Kommunikation & Netzwerke / Large Cap /
